136 related articles for article (PubMed ID: 3855489)
1. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma.
Eisenbach L; Segal S; Feldman M
J Natl Cancer Inst; 1985 Jan; 74(1):77-85. PubMed ID: 3855489
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic enzymes in tumor metastasis. II. Collagenase type IV activity in subcellular fractions of cloned tumor cell populations.
Eisenbach L; Segal S; Feldman M
J Natl Cancer Inst; 1985 Jan; 74(1):87-93. PubMed ID: 2982056
[TBL] [Abstract][Full Text] [Related]
3. Organ-site dependence for the production of urokinase-type plasminogen activator and metastasis by human renal cell carcinoma cells.
Gohji K; Nakajima M; Boyd D; Dinney CP; Bucana CD; Kitazana S; Kamidono S; Fidler IJ
Am J Pathol; 1997 Dec; 151(6):1655-61. PubMed ID: 9403716
[TBL] [Abstract][Full Text] [Related]
4. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells.
Nakanishi H; Oguri K; Takenaga K; Hosoda S; Okayama M
Lab Invest; 1994 Mar; 70(3):324-32. PubMed ID: 7511714
[TBL] [Abstract][Full Text] [Related]
5. Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency.
Katzav S; Segal S; Feldman M
J Natl Cancer Inst; 1985 Aug; 75(2):307-18. PubMed ID: 3894752
[TBL] [Abstract][Full Text] [Related]
6. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
Talmadge JE; Fidler IJ
J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
[TBL] [Abstract][Full Text] [Related]
7. Metastatic heterogeneity of cells from Lewis lung carcinoma.
van Lamsweerde AL; Henry N; Vaes G
Cancer Res; 1983 Nov; 43(11):5314-20. PubMed ID: 6616467
[TBL] [Abstract][Full Text] [Related]
8. Tumor heterogeneity and stability of the metastatic phenotype of mouse KHT sarcoma cells.
Chambers AF; Hill RP; Ling V
Cancer Res; 1981 Apr; 41(4):1368-72. PubMed ID: 7214323
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
10. Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.
Dobrossy L; Pavelic ZP; Vaughan M; Porter N; Bernacki RJ
Cancer Res; 1980 Sep; 40(9):3281-5. PubMed ID: 7427942
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages of mouse mammary tumors. II. Differential distribution of macrophages from metastatic and nonmetastatic tumors.
Mahoney KH; Fulton AM; Heppner GH
J Immunol; 1983 Oct; 131(4):2079-85. PubMed ID: 6311907
[TBL] [Abstract][Full Text] [Related]
12. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase.
Shah V; Kumar S; Zirvi KA
In Vivo; 1994; 8(3):321-6. PubMed ID: 7803712
[TBL] [Abstract][Full Text] [Related]
13. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones.
Aboud M; Kingsmore S; Segal S
Nat Immun; 1993; 12(1):17-24. PubMed ID: 8431660
[TBL] [Abstract][Full Text] [Related]
14. Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells.
Katzav S; De Baetselier P; Tartakovsky B; Feldman M; Segal S
J Natl Cancer Inst; 1983 Aug; 71(2):317-24. PubMed ID: 6576189
[TBL] [Abstract][Full Text] [Related]
15. Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability.
Milas L; Wike J; Hunter N; Volpe J; Basic I
Cancer Res; 1987 Feb; 47(4):1069-75. PubMed ID: 3802091
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
[TBL] [Abstract][Full Text] [Related]
17. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
18. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
[TBL] [Abstract][Full Text] [Related]
19. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
20. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
Wang BS; McLoughlin GA; Richie JP; Mannick JA
Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
